We are live on ! Find out more

3,180 hedge funds and large institutions have $207B invested in Merck in 2023 Q1 according to their latest regulatory filings, with 164 funds opening new positions, 1,203 increasing their positions, 1,448 reducing their positions, and 148 closing their positions.

New
Increased
Maintained
Reduced
Closed

23% more call options, than puts

Call options by funds: $1.84B | Put options by funds: $1.49B

11% more first-time investments, than exits

New positions opened: 164 | Existing positions closed: 148

3.05% more ownership

Funds ownership: 75.53%78.57% (+3%)

4% less capital invested

Capital invested by funds: $216B → $207B (-$9.61B)

2% less funds holding

Funds holding: 3,2353,180 (-55)

17% less repeat investments, than reductions

Existing positions increased: 1,203 | Existing positions reduced: 1,448

23% less funds holding in top 10

Funds holding in top 10: 342262 (-80)

Holders
3,180
Holders Change
-55
Holders Change %
-1.7%
% of All Funds
50.67%
Holding in Top 10
262
Holding in Top 10 Change
-80
Holding in Top 10 Change %
-23.39%
% of All Funds
4.17%
New
164
Increased
1,203
Reduced
1,448
Closed
148
Calls
$1.84B
Puts
$1.49B
Net Calls
+$343M
Net Calls Change
+$245M
Name Holding Trade Value Shares
Change
Change in
Stake
FMLI
301
Fukoku Mutual Life Insurance
Japan
$48.4M
BSA
302
Braun Stacey Associates
New York
$48.2M +$24.4M +225,983 +100%
WT
303
Whittier Trust
California
$48M +$945K +8,755 +2%
URS
304
Utah Retirement Systems
Utah
$48M +$151K +1,400 +0.3%
CIM
305
CCLA Investment Management
United Kingdom
$47.8M -$13.7M -126,618 -22%
CCM
306
Compass Capital Management
Minnesota
$47.1M +$47.8M +442,440 New
DILIC
307
Dai-ichi Life Insurance Company
Japan
$46.7M +$833K +7,720 +2%
LWCFA
308
Loring Wolcott & Coolidge Fiduciary Advisors
Massachusetts
$46.6M -$445K -4,118 -0.9%
OAM
309
Oppenheimer Asset Management
New York
$46.6M -$622K -5,757 -1%
X
310
Xponance
Pennsylvania
$46.5M +$1.4M +12,970 +3%
NC
311
Nicholas Company
Wisconsin
$46.4M -$327K -3,025 -0.7%
PA
312
Pinnacle Associates
New York
$46.3M -$2.5M -23,132 -5%
WBC
313
Westpac Banking Corp
Australia
$46.2M -$5.18M -47,983 -10%
MGIM
314
M&G Investment Management
United Kingdom
$46.2M -$11.7M -108,088 -20%
COPPSERS
315
Commonwealth of Pennsylvania Public School Employees Retirement System
Pennsylvania
$45.7M +$134K +1,244 +0.3%
ST
316
Sabal Trust
Florida
$45M -$1.09M -10,077 -2%
SF
317
Synovus Financial
Georgia
$44.6M -$338K -3,134 -0.7%
BF
318
BOK Financial
Oklahoma
$44.5M -$4.56M -42,268 -9%
T
319
TOBAM
France
$44.3M +$54.6K +506 +0.1%
DWA
320
Douglass Winthrop Advisors
New York
$44.3M -$691K -6,403 -2%
FT
321
Fiduciary Trust
Massachusetts
$44.1M -$542K -5,020 -1%
FWCM
322
Ferguson Wellman Capital Management
Oregon
$43.9M +$133K +1,232 +0.3%
SAI
323
Systematic Alpha Investments
New Jersey
$43.7M
RT
324
Rockland Trust
Massachusetts
$43.5M -$176K -1,628 -0.4%
IMRF
325
Illinois Municipal Retirement Fund
Illinois
$43.4M -$2.92M -27,055 -6%

MRK Hedge Fund Activity: Q1 2023 in Review

3,180 of the 6,276 institutional investors tracked by Wall St. Rank reported a position in Merck (MRK) for Q1 2023, worth a combined $207B — down 4.4% from $216B a quarter earlier.

Buyers outnumbered sellers: 164 funds opened new MRK positions and 148 closed out — a net gain of 16 holders — while 1,203 added to existing stakes and 1,448 trimmed.

The largest buyer was Vanguard Group, adding an estimated $1.81B. The largest seller was BlackRock, cutting an estimated $608M.

  • 3,180 institutional investors held Merck (MRK) as of Q1 2023, down from 3,235 in Q4 2022.
  • Funds reported $207B of Merck stock for Q1 2023, down 4.4% quarter-over-quarter.
  • 164 funds opened new Merck positions in Q1 2023 and 148 closed out, a net change of +16 holders.
  • The largest Merck buyer in Q1 2023 was Vanguard Group, an estimated $1.81B added.
  • The largest Merck seller in Q1 2023 was BlackRock, an estimated $608M sold.

Based on aggregated 13F filings for Q1 2023.